ASX - Delayed Quote AUD
Cyclopharm Limited (CYC.AX)
1.1500
-0.1100
(-8.73%)
At close: 4:10:04 PM GMT+10
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM | CEO, MD, Company Secretary & Director | 655k | -- | 1965 |
| Mr. Jason Smith | Chief Financial Officer | 353.34k | -- | -- |
| Mr. Mathew Farag | Chief Operating Officer | 449.16k | -- | -- |
| Ms. Sally-Ann Cornelius | Head of Sales | -- | -- | -- |
| Ms. Niamh McAree | Head of Quality and Regulatory | -- | -- | -- |
| Mr. Chris Quinn | Head of Service | -- | -- | -- |
| Ms. Sui Ling Cheah | Financial Controller | 63.73k | -- | 1970 |
| Mr. Lynn McLauchlin | General Manager of Canada | 172k | -- | -- |
| Mr. Gary T. Somerville | Quality & Regulatory Manager | 151.96k | -- | -- |
Cyclopharm Limited
1 The Crescent
Unit 4
Kingsgrove, NSW 2208
Australia
- Sector:
- Healthcare
- Industry: Medical Distribution
- Full Time Employees:
- 95
Description
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Corporate Governance
Cyclopharm Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 24, 2025 at 9:02 PM UTC
Cyclopharm Limited Earnings Date
Recent Events
September 1, 2023 at 12:00 AM UTC
Ex-Dividend Date